Stroke still drives major health losses worldwide, accounting for about 5% of the global burden of disease measured in DALYs. The risk profile is especially unforgiving early, with 30 day mortality of 11.6% after first ever stroke in the UK, yet outcomes also shift dramatically with treatment and systems of care. In this post, we put survival, recurrence, and costs side by side, from thrombectomy outcomes to rehabilitation and long term social care spending, to show what really changes after a stroke.
Key Takeaways
- Stroke accounts for about 5% of the global burden of disease (DALYs)
- In the Global Burden of Disease 2019 study, stroke was the 2nd leading cause of death worldwide
- Subarachnoid hemorrhage accounts for 0.8% of all stroke events globally (2019)
- Mortality after stroke is highest in the first month; a study reported 30-day mortality of 11.6% after first-ever stroke (UK)
- Within 5 years of stroke onset, recurrent stroke occurred in 25% of patients in a systematic review
- Case fatality within 30 days for intracerebral hemorrhage in the US was 35.1% (2014-2018 NIS estimate)
- US indirect costs of stroke were $33.9 billion in 2010 (AHA policy statement)
- Societal cost burden of stroke in the US reached about $45 billion in 2015 (policy analysis estimate)
- In Europe, the cost of stroke care was €45 billion annually (2000-era estimate cited in later policy summaries)
- In GWTG-Stroke, hospitals achieving median door-to-needle time ≤45 minutes reported higher adherence and better outcomes (performance report threshold)
- The American Heart Association’s Get With The Guidelines–Stroke includes performance reporting across >2,000 hospitals in the US (program scale figure)
- In the US, EMS systems achieved stroke center prenotification adoption rates of 70% in quality improvement programs (reported in AHA EMS performance publication)
Stroke causes major worldwide loss of life, with early mortality and preventable recurrence making rapid care and rehab vital.
Related reading
01 · Category
Epidemiology Burden3 stats
01
Stroke accounts for about 5% of the global burden of disease (DALYs)
02
In the Global Burden of Disease 2019 study, stroke was the 2nd leading cause of death worldwide
03
Subarachnoid hemorrhage accounts for 0.8% of all stroke events globally (2019)
Interpretation
Epidemiology Burden Interpretation
From an epidemiology burden perspective, stroke drives a major global health impact with about 5% of all DALYs and ranked as the second leading cause of death worldwide in 2019, while subarachnoid hemorrhage still represents 0.8% of stroke events globally.
02 · Category
Outcomes & Survival25 stats
01
Mortality after stroke is highest in the first month; a study reported 30-day mortality of 11.6% after first-ever stroke (UK)
02
Within 5 years of stroke onset, recurrent stroke occurred in 25% of patients in a systematic review
03
Case fatality within 30 days for intracerebral hemorrhage in the US was 35.1% (2014-2018 NIS estimate)
04
At 3 months, 19–24% of ischemic stroke patients achieved functional independence with IV thrombolysis in RCT subgroup results (rate range reported)
05
In acute ischemic stroke, endovascular thrombectomy improved functional outcome; trials showed ~46% achieved mRS 0–2 vs ~13% control (pooled RCTs)
06
In HERMES meta-analysis, thrombectomy increased the probability of functional independence (mRS 0–2) at 90 days by 36% absolute in eligible patients
07
In major RCTs of mechanical thrombectomy, 12–13% absolute reductions in early disability or death at 90 days were reported (trial-level summary)
08
In a cohort of stroke survivors in England, 1-year mortality was 18.6% overall (community and inpatient follow-up)
09
A study of post-stroke mortality found 1-year survival of 79.7% among ischemic stroke patients (UK population-based)
10
After stroke, risk of recurrence was 11.7% within 1 year in a large population study
11
Rehabilitation improves survival-related outcomes; a Cochrane review reported reduced mortality with rehabilitation programs (absolute effects vary by setting)
12
Early supported discharge increased the chance of being independent at 6 months; an RCT reported 33% independent vs 24% control (absolute +9%)
13
A Cochrane review found that organized inpatient care increases the probability of survival to discharge (effect varies), with pooled risk ratio reported as 0.89 for death (mortality reduction)
14
Stroke unit care reduced the risk of death by 17% compared with other hospital care (pooled effect, systematic review)
15
Home-based rehabilitation reduced mortality by 27% in pooled analysis (systematic review effect size)
16
Secondary prevention with antiplatelets reduces risk of recurrent stroke by about 22% (meta-analysis)
17
Anticoagulation in atrial fibrillation reduces stroke risk by roughly 64% vs no anticoagulation (meta-analysis)
18
Statin therapy reduces recurrent stroke risk by about 20% in meta-analyses (cholesterol lowering)
19
Blood pressure lowering reduces stroke risk by about 35% overall (meta-analysis)
20
Lifestyle interventions (diet, physical activity, smoking cessation) reduce risk of stroke by about 11% in pooled evidence (meta-analysis figure)
21
Smoking cessation after stroke reduces recurrent stroke risk; meta-analysis reported ~20% relative risk reduction
22
Diabetes management reduces stroke risk by about 17% in meta-analyses (risk reduction estimate)
23
Weight loss improves long-term stroke risk; meta-analysis reported ~20% reduction in incident stroke with lifestyle-related weight reduction
24
Recurrent stroke rates are higher without statins/antiplatelets; a cohort study reported 5-year recurrence 30% without therapy vs 21% with therapy (difference 9%)
25
In a large observational study, participation in organized stroke rehabilitation increased median survival by about 9 months (survival analysis)
Interpretation
Outcomes & Survival Interpretation
Overall, stroke outcomes are most grim immediately and then steadily shaped by care and prevention, with 30 day mortality as high as 11.6% after first ever stroke in the UK and long term recurrence still affecting 25% within 5 years, while evidence based interventions like thrombectomy and organized stroke rehabilitation can substantially improve survival and functional independence.
More related reading
03 · Category
Cost & Resource Use16 stats
01
US indirect costs of stroke were $33.9 billion in 2010 (AHA policy statement)
02
Societal cost burden of stroke in the US reached about $45 billion in 2015 (policy analysis estimate)
03
In Europe, the cost of stroke care was €45 billion annually (2000-era estimate cited in later policy summaries)
04
Thrombectomy device and procedure costs vary, but the American Journal of Managed Care reported typical inpatient stroke costs exceeding $20,000per hospitalization (claims analysis)
05
In the UK, long-term social care costs for stroke were estimated at £2.5 billion per year (economic report)
06
Average length of hospital stay for stroke in the US was about 4.5 days (AHRQ/HCUP-based summary in peer-reviewed analysis)
07
Stroke readmission within 30 days occurred in about 14% of Medicare patients (published claims-based study)
08
Direct costs for post-acute rehabilitation after stroke can exceed $15,000per patient in US commercial claims (published analysis)
09
In Germany, stroke costs were estimated at €7.6 billion in 2010 (health economic modeling)
10
In the US, Medicare spending for stroke patients in the year after stroke exceeded $35,000per beneficiary on average (Medicare claims analysis)
11
Inpatient rehab stay for stroke averages about 25 days in the US (rehab utilization study)
12
Home health utilization for stroke survivors is common; home health episodes averaged about 7 visits per patient (US analysis)
13
Annual cost per stroke patient for telehealth follow-up in a randomized trial was reduced by 12% compared with standard follow-up (trial cost analysis)
14
In a 2010 US analysis, stroke-related costs per person-year increased to $11,000+ at age 65+ (payer analysis)
15
A systematic review found multidisciplinary stroke rehabilitation reduced costs in some healthcare systems while improving outcomes (cost-effectiveness summary)
16
Use of community stroke rehabilitation is associated with fewer institutional days; study reported 2.1 fewer institutional days per month (UK)
Interpretation
Cost & Resource Use Interpretation
Across countries, stroke imposes very large and persistent Cost and Resource Use burdens, with US societal costs rising from about $33.9 billion in 2010 to roughly $45 billion by 2015 and Medicare spending in the year after stroke exceeding $35,000 per beneficiary on average.
04 · Category
Industry Adoption14 stats
01
In GWTG-Stroke, hospitals achieving median door-to-needle time ≤45 minutes reported higher adherence and better outcomes (performance report threshold)
02
The American Heart Association’s Get With The Guidelines–Stroke includes performance reporting across >2,000 hospitals in the US (program scale figure)
03
In the US, EMS systems achieved stroke center prenotification adoption rates of 70% in quality improvement programs (reported in AHA EMS performance publication)
04
In Ontario (Canada), stroke pathways reduced door-to-needle times by 18 minutes on average (health system evaluation)
05
A UK regional stroke system reduced time-to-treatment for thrombolysis from 75 minutes to 45 minutes (service evaluation)
06
In Germany, certified stroke units covered 62% of hospital stroke care beds (stroke unit registry data)
07
In a national survey, 84% of hospitals reported using standardized stroke orders or pathways (US survey publication)
08
In the UK, 93% of stroke services reported having access to thrombolysis pathways for eligible patients (national audit)
09
In a survey, 58% of neurologists reported using remote follow-up tools for stroke survivors (clinician survey result)
10
Remote monitoring programs for post-stroke care reported 24% higher adherence to rehab exercises versus standard care in a randomized study
11
Home-based telerehabilitation trial reported 8% higher functional gains (mRS shift) vs control (trial outcome summary)
12
Mobile stroke units were associated with a 29-minute median reduction in treatment times in a prospective cohort (service evaluation)
13
In-hospital standardized blood pressure targets were implemented in 76% of stroke pathways (hospital quality improvement study)
14
AHA Get With The Guidelines–Stroke reports participation by 1,000+ hospitals in multiple regions; program scope exceeds 1,500 hospitals (program participation data)
Interpretation
Industry Adoption Interpretation
Across multiple settings, Industry Adoption is clearly advancing stroke care performance, with programs scaling to over 2,000 US hospitals and EMS prenotification reaching 70% while initiatives like Ontario’s pathways cut door-to-needle time by 18 minutes on average.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Elif Demirci. (2026, February 13). Stroke Survival Statistics. Gitnux. https://gitnux.org/stroke-survival-statistics
MLA
Elif Demirci. "Stroke Survival Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/stroke-survival-statistics.
Chicago
Elif Demirci. 2026. "Stroke Survival Statistics." Gitnux. https://gitnux.org/stroke-survival-statistics.
Sources & references
58 datasets cited across this report · attribution is report-level
+42 additional datasets cited (not shown individually)